Geode Capital Management, LLC Protalix Bio Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.52 Trillion
- Q3 2025
A detailed history of Geode Capital Management, LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 819,777 shares of PLX stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
819,777
Previous 826,333
0.79%
Holding current value
$1.52 Million
Previous $1.22 Million
49.59%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PLX
# of Institutions
82Shares Held
10.6MCall Options Held
23.6KPut Options Held
95.4K-
Opaleye Management Inc. Boston, MA2.58MShares$4.8 Million0.96% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.32MShares$2.45 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL902KShares$1.68 Million0.0% of portfolio
-
Stratos Wealth Partners, Ltd.500KShares$930,0000.01% of portfolio
-
State Street Corp Boston, MA499KShares$927,2970.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $92.5M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...